UPDATED Jul 06, 2022
Discover large cap Australian Pharmaceuticals & Biotech companies that are on the ASX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CSLCSL | AU$286.13 | 6.3% | 2.5% | AU$137.8b | AU$318.87 | PE40.1x | E14.8% | 1.1% | ||
| TLXTelix Pharmaceuticals | AU$5.19 | 14.6% | -7.7% | AU$1.6b | AU$8.15 | PS213.8x | E56.3% | n/a | ||
| IMUImugene | AU$0.22 | 22.2% | -33.3% | AU$1.3b | n/a | PS152.8x | E-0.7% | n/a | ||
| CUVClinuvel Pharmaceuticals | AU$16.24 | 9.4% | -41.3% | AU$802.4m | AU$27.57 | PE33.3x | E29.4% | 0.2% | ||
| MSBMesoblast | AU$0.81 | 32.8% | -60.5% | AU$526.4m | AU$1.53 | PS35.7x | E65.1% | n/a | ||
| MYXMayne Pharma Group | AU$0.28 | 14.0% | -12.3% | AU$503.0m | n/a | PS1.3x | E86.4% | 0% | ||
| NEUNeuren Pharmaceuticals | AU$3.75 | -1.3% | 145.1% | AU$472.4m | AU$6.14 | PS147.8x | E38.7% | n/a | ||
| OPTOpthea | AU$1.16 | 5.0% | -11.2% | AU$406.2m | AU$1.70 | PB2.7x | E33.1% | n/a | ||
| RACRace Oncology | AU$2.50 | 28.2% | -30.2% | AU$398.8m | n/a | PS564.3x | n/a | n/a | ||
| TRJTrajan Group Holdings | AU$1.99 | -0.5% | -13.1% | AU$297.5m | AU$3.22 | PS3.6x | E80.9% | n/a | ||
| IHLIncannex Healthcare | AU$0.23 | 9.5% | -4.2% | AU$294.9m | n/a | PS410.7x | n/a | n/a | ||
| SPLStarpharma Holdings | AU$0.68 | -8.1% | -49.3% | AU$277.1m | n/a | PS81x | n/a | n/a | ||
| IMMImmutep | AU$0.31 | 6.9% | -39.8% | AU$264.8m | AU$1.25 | PS70.9x | E62.9% | n/a | ||
| ARXAroa Biosurgery | AU$0.72 | 9.1% | -41.0% | AU$246.8m | AU$1.25 | PS6.9x | E87.7% | n/a | ||
| PARParadigm Biopharmaceuticals | AU$1.01 | 4.1% | -50.2% | AU$231.1m | AU$1.90 | PS3589.3x | E39.2% | n/a | ||
| PYCPYC Therapeutics | AU$0.066 | 1.5% | -58.8% | AU$209.9m | n/a | PS23.2x | n/a | n/a | ||
| AVHAVITA Medical | AU$1.66 | 19.4% | -68.5% | AU$207.5m | AU$3.42 | PS5.3x | E49.0% | n/a | ||
| PBPProbiotec | AU$2.35 | 4.4% | 13.5% | AU$191.1m | AU$3.04 | PE23.1x | E25.2% | 2.1% | ||
| GSSGenetic Signatures | AU$1.13 | -2.6% | -19.3% | AU$162.0m | AU$1.38 | PE82.7x | E-90.2% | n/a | ||
| ADOAnteoTech | AU$0.078 | 20.0% | -69.4% | AU$155.1m | n/a | PS53.8x | n/a | n/a | ||
| RCERecce Pharmaceuticals | AU$0.82 | -7.3% | -12.2% | AU$146.6m | n/a | PS147.1x | n/a | n/a | ||
| CAUCronos Australia | AU$0.24 | -2.0% | 113.0% | AU$135.0m | n/a | PS6.2x | n/a | n/a | ||
| CU6Clarity Pharmaceuticals | AU$0.50 | -2.0% | n/a | AU$129.0m | AU$1.55 | PS27.6x | E-26.6% | n/a | ||
| MVPMedical Developments International | AU$1.76 | 20.2% | -60.3% | AU$125.1m | AU$4.75 | PS5.6x | E53.2% | 0% |